Arrhythmogenic mechanism of a novel ryanodine receptor mutation underlying sudden cardiac death

Yunyun Qian1,2, Dongchuan Zuo3,4, Jing Xiong1,2

  • 1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Jingan District, Shanghai 200072, China.

Abstract

Insights

A novel ryanodine receptor 2 (RyR2) mutation, A690E, causes inherited cardiac disease and sudden death by disrupting calcium release. This study elucidates the mutation’s pathogenic basis in RyR2-linked arrhythmias.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Genetics of Cardiac Disease

Background:

  • Ryanodine receptor 2 (RyR2) is critical for cardiac excitation-contraction coupling.
  • RyR2 dysfunction is implicated in inherited arrhythmogenic cardiac diseases and sudden cardiac death.
  • Identifying novel mutations and their mechanisms is crucial for understanding these conditions.

Purpose of the Study:

  • To investigate the pathogenic basis of a novel RyR2 mutation, A690E, identified in a patient with a family history of sudden cardiac death.
  • To characterize the functional consequences of the A690E mutation in RyR2.

Main Methods:

  • Generation of a mouse model harboring the RyR2 A690E mutation.
  • In vivo characterization of arrhythmias and ex vivo optical mapping of hearts and isolated cardiomyocytes.
  • Analysis of calcium handling, RyR2-mediated calcium leak, and RyR2-FK506 binding protein interaction.

Main Results:

  • The A690E mutation induced adrenergic-dependent ventricular arrhythmias in mice, mirroring patient symptoms.
  • Isolated A690E hearts and cardiomyocytes exhibited arrhythmogenesis, frequency-dependent calcium transient alternans, and a shift towards discordant alternans.
  • Mutant RyR2 displayed increased sensitivity to calcium, elevated diastolic calcium leak, and impaired calcium leak-reuptake balance, impacting RyR2-FKBP interaction.

Conclusions:

  • The novel RyR2 A690E mutation is pathogenic and associated with sudden cardiac death.
  • The study provides mechanistic insights into RyR2-mediated calcium release defects underlying life-threatening cardiac arrhythmias.
  • Understanding these molecular defects is vital for developing therapeutic strategies for inherited cardiac diseases.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
962
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
18
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.3K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
1.0K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16